NCT03789214View on ClinicalTrials.gov

Medical Management of Sleep Disturbance During Opioid Tapering

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 10, 2021

Study Completion Date

June 10, 2021

Conditions
Opioid DependenceOpioid WithdrawalSleep Disturbance
Interventions
DRUG

Placebo oral capsule

Placebo Sleep Medication

DRUG

Low Dose Suvorexant

Low Dose Suvorexant

DRUG

High Dose Suvorexant

High Dose Suvorexant

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT03789214 - Medical Management of Sleep Disturbance During Opioid Tapering | Biotech Hunter | Biotech Hunter